Skip to content

Kura Oncology KURA Change in AR

Change in AR at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$595M-35.7%
Amgen logo
AmgenAMGN
-$413M-132%
Exelixis logo
ExelixisEXEL
$42.03M+161%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$120K-101%
AbbVie logo
AbbVieABBV
-$87M-106%
Nuvation Bio logo
Nuvation BioNUVB
$6.65M+154%

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$919.7M+81.6%
Enterprise value$904.89M+90.7%
P/S12.8×+3.5×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kura Oncology's change in AR?
Kura Oncology (KURA) reported change in AR of $544K in Q1 2026.
How has Kura Oncology's change in AR changed year-over-year?
Kura Oncology's change in AR decreased by 98.8% year-over-year, from $46.69M to $544K.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.